Company Index
WuXi Biologics
WuXi Biologics
NEWS
Ant-backed MYBank is fined for anti-money laundering violations. Chinese and Singaporean regulators vow to support the ETF connect
Feb.9 2022 09:20 AM
The Chinese drugmaker suspended trading of its shares in Hong Kong after its addition to the Commerce Department’s unverified list triggered a record sell-off
Feb.8 2022 19:29 PM
Aug.3 2019 02:15 AM
Sale will reduce company’s stake in its Hong Kong-listed subsidiary to 55.34%
Jun.22 2018 00:10 AM
Chinese pharmaceutical firm gains exclusive rights to commercialize medicines in Greater China
Jun.6 2018 17:56 PM
Biotech highflier chooses tax-friendly EU member for first overseas facility
May.9 2018 18:22 PM
After lottery ahead of WuXi AppTec’s listing, 0.3% of shares not taken up
May.2 2018 20:36 PM
Chinese pharmaceutical firm gets green light for $910 million IPO at home in a mere 50 days
Mar.28 2018 19:50 PM
FDA gives nod after Trogarzo showed strong results for patients with drug-resistant strains of the virus that causes AIDS
Mar.7 2018 19:19 PM
Mindray Medical, WuXi Biologics among a new generation of drug and device makers cashing in on rapid growth in China’s healthcare system
May.31 2017 13:19 PM
- Feb 23, 2022 08:00 AM
- Feb 23, 2022 08:00 AM
- Feb 23, 2022 08:00 AM
MOST POPULAR
- 1After Junk Downgrade, China’s Largest Developer Announces $441 Million Bond Buyback
- 2Less Than 0.1% of Shanghai’s Hospitalized Covid Patients Develop Severe Illness, Study Shows
- 3CATL Unveils Battery That Power a Car Up to 1,000 Kilometers on One Charge
- 4China Junk Bond Selloff Enters New Phase With Record Fosun Rout
- 5China Resumes More International Flights as Crippling Covid Curbs Ease
Sign in with Google
Sign in with Facebook
Sign in with 财新